Biosyn Pharmaceuticals delivers premium-quality medications with a focus on accessibility, scientific integrity, and human-centered care — specialized in Pediatrics, Otolaryngology, and Pulmonology.
Founded in November 2023, Biosyn Pharmaceuticals emerged from a simple yet powerful belief — quality medication should never be a privilege. We blend scientific rigor, ethical sourcing, and human-centered design to deliver therapies that matter.
Every product manufactured under strict GMP standards.
Cost-effective treatments without compromising on standards.
Targeting unmet needs across the Egyptian market.
"We believe that everyone should have access to the standard level of medications they need — without suffering financial hardship."
A focused portfolio of nasal-care solutions — Calmare, Calmare Plus, and Panmist Gel — formulated for safety and everyday use.
Nine compounds in active development across our therapeutic areas.
Deep focus in Pediatrics, Otolaryngology, and Pulmonology.
Articles, treatment guidance, and case studies.
GMP standards and EDA-notified products.
Biosyn's commitment doesn't end at the pharmacy counter. We work to ensure that access to standard-quality medication — particularly for children and underserved patients — is treated as a baseline, not a bonus.
Cost-effective pricing strategy across our entire portfolio.
Patient and caregiver education in pediatric and ENT care.
Ethical sourcing, mindful waste management, sustainable practice.
— Biosyn's Founding Belief
Partner with us, request product information, or learn more about Biosyn's mission to make quality care accessible.
Get in Touch